$9.25
+0.40 (+4.52%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+202.1% upside
Low Target
$24.18
Average Target
$27.94
High Target
$39.76
Current Price
$9.25
Current
$9.25
$9.25
Target
$27.94
$27.94
$24.18
$27.94 avg
$39.76
Scenario Analysis
Bear Case
$24.18
161.4%
Low target
Base Case
$27.94
+202.1%
Avg target
Bull Case
$39.76
+329.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$23.57
-60.8% from high
52-Week Low
$1.91
+385.6% from low
Target vs 52W High
$27.94
+18.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |